Many cancer patients in the last 20+ years decided to use the benefits of high doses of vitamin C instead of chemotherapy as the means for fighting cancer. What use to be a last hope treatment by a few doctors aware of its potential benefits, has not become a potentially very promising way to treat patient.
by Joe Martino
High-dose vitamin C injections have shown positive results in fighting cancer cells in studies done in vitro, on mice and on humans. Peer-reviewed medical research has been recently published in the journal Science Translational Medicine that reports the findings of a team of researchers from the University of Kansas who tested the effects of vitamin C given in high doses intravenously on a group of human subjects with cancer. They found that the injections fought cancer cells yet left healthy cells well intact unlike chemotherapy.
The BBC reports that vitamin C effectively targeted ovarian cancer cells while completely avoiding healthy cells. The benefits of high-dose vitamin C injections were also observed in conjunction with chemotherapy. Some are suggesting that the injections provide a great boost alongside chemo treatment. However chemo does destroy all cells, both healthy and not and is often the cause of death for cancer patients.
Research on …
Patients are looking for safe and low-cost choices in their management of cancer… Intravenous vitamin C has that potential based on our basic science research and early clinical data.” Dr. Jeanne Drisko, a co-author of the study.
Researchers admit more research is unlikely because drug companies cannot patent vitamins.
Generally the next step in this type of research would be creating human clinical trials that are much larger. Regardless of the fact this study is quite convincing, larger and more widespread testing would need to be done. But these types of trials cost a great deal of money. While clinical trials are often funded by large drug companies when testing out new medications, the researchers involved in this study feel drug companies won’t fund such research because they can’t patent the natural substance that is vitamin C. Allowing research like this could potentially destroy the multi-billion dollar cancer industry.
Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies… We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C. Qi Chen, lead author of the new study.
Since the start of a strong advocacy movement for high doses of vitamin C, there has been an absence of large scale formal trials in the 10 to 200+ grams per day range to ascertain whether or not high doses are safe. The few studies that have conduced so far, have found the single repeatable side-effect of a mild laxative effect if consumed too quickly. More extensive studies need to be carried out to fully explore its benefits. For the moment a tolerable upper limit of vitamin C is set at 2000 milligrams. Some doctors however suggest that their patients were treated with 10,000 milligrams throughout the day to fight off and beat some cancers.
Make sure to read the rest of the article Naturalblaze.
Leave a Reply